Fibroblast growth factor signaling in the developing tracheoesophageal fistula.

BACKGROUND/PURPOSE The Adriamycin-induced rat model of esophageal atresia and tracheoesophageal fistula (EA/TEF) provides a reliable system for the study of EA/TEF pathogenesis. The authors previously hypothesized that faulty branching lung morphogenesis pathways were a critical component of its pathogenesis. The authors have found evidence for faulty fibroblast growth factor (FGF) signaling related to epithelial-mesenchymal interactions in the fistula tract. To better define FGF signaling, the differential expression of FGF ligands and their receptors between lung, fistula tract, and esophagus are described. METHODS Time-dated pregnant, Sprague-Dawley rats were injected with Adriamycin (2 mg/kg intraperitoneally) on days 6 through 9 of gestation. Tissues were processed for histology and reverse transcriptase polymerase chain reaction. FGF-1, -7 and -10 were measured from whole lung, fistula tract, and esophagus of TEF or normal embryos. Expression of FGF2RIIIb and FGF2RIIIc receptors was measured in isolated epithelium and mesenchyme of lung and fistula tract of TEF embryos as well as lung and esophagus from normal controls. RESULTS FGF-1 mRNA was present in the fistula tract and normal and Adriamycin-exposed lung but absent from whole esophagus. Interestingly, FGF-7 mRNA was present only in normal lung. FGF-10 was present in all tissues examined. FGF2RIIIb mRNA was absent in fistula mesenchyme but present in all other tissues examined. However, the splice variant FGF2RIIIc mRNA was present in all tissues examined. CONCLUSIONS These findings support defective FGF signaling in the rat model of EA/TEF. Absence of FGF-7 mRNA in Adriamycin-exposed tissues suggests the primary effect of Adriamycin may be to inhibit FGF-7 expression. Moreover, absence of FGF2RIIIb in fistula mesenchyme may be caused by loss of positive feedback from FGF-7, its normal obligate ligand. Understanding these specific defects in FGF signaling may provide insight into faulty mechanisms of EA/TEF.

[1]  K. Miller,et al.  Thyroid transcription factor-1 expression in the human neonatal tracheoesophageal fistula. , 2002, Journal of pediatric surgery.

[2]  K. Prasadan,et al.  Complete discontinuity of the distal fistula tract from the developing gut: Direct histologic evidence for the mechanism of tracheoesophageal fistula formation , 2002, The Anatomical record.

[3]  M. Longaker,et al.  Defective fibroblast growth factor signaling allows for nonbranching growth of the respiratory-derived fistula tract in esophageal atresia with tracheoesophageal fistula. , 2000, Journal of pediatric surgery.

[4]  M. Mathur,et al.  A histopathological study of esophageal atresia and tracheoesophageal fistula. , 2000, Journal of pediatric surgery.

[5]  M. Longaker,et al.  TTF-1 and HNF-3beta in the developing tracheoesophageal fistula: further evidence for the respiratory origin of the distal esophagus'. , 1999, Journal of pediatric surgery.

[6]  S. Mackem,et al.  Soluble dominant‐negative receptor uncovers essential roles for fibroblast growth factors in multi‐organ induction and patterning , 1998, The EMBO journal.

[7]  B. Hogan,et al.  Fibroblast growth factor 10 (FGF10) and branching morphogenesis in the embryonic mouse lung. , 1997, Development.

[8]  J. Brody,et al.  FGF‐1 and FGF‐7 induce distinct patterns of growth and differentiation in embryonic lung epithelium , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.

[9]  A. Tanswell,et al.  Keratinocyte growth factor and its receptor are involved in regulating early lung branching. , 1996, Development.

[10]  D. Warburton,et al.  Keratinocyte growth factor and embryonic rat lung morphogenesis. , 1996, American journal of respiratory cell and molecular biology.

[11]  H. Nogawa,et al.  Branching morphogenesis of embryonic mouse lung epithelium in mesenchyme-free culture. , 1995, Development.

[12]  C. Bagwell,et al.  Unilateral pulmonary agenesis, esophageal atresia, and distal tracheoesophageal fistula. , 1995, The Annals of thoracic surgery.

[13]  I. Mason.  The ins and outs of fibroblast growth factors , 1994, Cell.

[14]  S. Werner,et al.  Targeted expression of a dominant negative FGF receptor blocks branching morphogenesis and epithelial differentiation of the mouse lung. , 1994, The EMBO journal.

[15]  F. Fuller-Pace,et al.  FGF-7 (keratinocyte growth factor) expression during mouse development suggests roles in myogenesis, forebrain regionalisation and epithelial-mesenchymal interactions , 1994, Mechanisms of Development.

[16]  D. Givol,et al.  Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). , 1993, Developmental biology.

[17]  M. Jaye,et al.  Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. , 1992, Biochimica et biophysica acta.

[18]  A. Hokama,et al.  Esophageal atresia with tracheo-esophageal fistula , 1986, Pediatric Surgery International.

[19]  J. Lewis,et al.  Pulmonary sequestration with bronchoesophageal fistula. , 1968, Journal of pediatric surgery.

[20]  M. Longaker,et al.  Defective epithelial-mesenchymal interactions dictate the organogenesis of tracheoesophageal fistula , 2000, Pediatric Surgery International.